Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/21/2025

Clinical Utility of Total Cholesterol to HDL Ratio

Introduction to the Ratio

  • The total cholesterol/HDL ratio is a valuable risk assessment tool, but should not be used as a treatment target, instead focus on absolute LDL cholesterol goals based on cardiovascular risk category, as recommended by the European guidelines 1
  • The total cholesterol/HDL cholesterol ratio combines atherogenic lipoproteins with protective HDL cholesterol into a single risk marker, making it clinically useful for cardiovascular risk stratification 1

Risk Assessment and Interpretation

  • The European guidelines explicitly state that no specific treatment goals are defined for HDL cholesterol, and the ratio should be used as a marker of increased risk rather than as a therapeutic target 2, 3, 1
  • A total cholesterol/HDL ratio is specifically recommended when using the SCORE cardiovascular risk model, particularly in patients with rheumatoid arthritis 4
  • HDL cholesterol <1.0 mmol/L (40 mg/dL) in men and <1.2 mmol/L (46 mg/dL) in women serve as markers of increased cardiovascular risk 2, 3

Treatment Approach

  • Treatment should focus on absolute LDL cholesterol goals based on cardiovascular risk category, rather than targeting a specific ratio 2, 3, 5, 1
  • For primary prevention in asymptomatic individuals, the general goal is total cholesterol <5 mmol/L (190 mg/dL) and LDL cholesterol <3 mmol/L (115 mg/dL) 2, 3
  • For high-risk individuals (10-year cardiovascular death risk ≥5%), the goal is total cholesterol <4.5 mmol/L (175 mg/dL) and LDL cholesterol <2.5 mmol/L (100 mg/dL) 2, 3
  • For secondary prevention in established CVD or diabetes, the goal is total cholesterol <4.5 mmol/L (175 mg/dL) and LDL cholesterol <2.5 mmol/L (100 mg/dL), with more recent guidelines suggesting even lower targets: LDL <1.8 mmol/L (70 mg/dL) or at least a 50% reduction in LDL for very high-risk patients 2, 3, 5

Calculation and Assessment

  • The Friedewald formula for calculating LDL cholesterol is invalid when triglycerides exceed 4.5 mmol/L (400 mg/dL), in such cases, use direct LDL measurement or newer calculation methods like the Sampson-NIH2 equation (valid up to triglycerides of 9 mmol/L) 5
  • Measure total cholesterol first in asymptomatic individuals for initial screening, and if total cholesterol ≥6.5 mmol/L (250 mg/dL), obtain complete fasting lipid profile including HDL and triglycerides 2, 3

Lipid Profile Ratios and Clinical Interpretation

Introduction to Lipid Ratios

  • The TC/HDL-C ratio provides additional risk stratification information beyond individual lipid components, according to the European Heart Journal 6, 7
  • The TC/HDL-C ratio is especially valuable in women and patients with diabetes or metabolic syndrome, where total cholesterol alone may be misleading, as noted by the European Heart Journal 6, 7

Total Cholesterol/HDL-C Ratio

  • The TC/HDL-C ratio captures cardiovascular risk more accurately than LDL-C/HDL-C ratio in patients with elevated triglycerides, as it accounts for atherogenic remnant particles not reflected in calculated LDL-C 6, 7

Clinical Application of Lipid Ratios

  • The European Society of Cardiology recommends using the Friedewald formula for LDL-C calculation, which is LDL-C = TC - HDL-C - TG/2.2 (mmol/L) or TG/5 (mg/dL), as cited in the European Heart Journal 6, 7
  • The American Heart Association suggests that the TC/HDL-C ratio is a useful marker for cardiovascular risk assessment, particularly in patients with rheumatoid arthritis or other inflammatory conditions 6, 7

REFERENCES

1

LDL/HDL Ratio as a Cardiovascular Risk Marker [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025